Top

Diabetologia

Published in:

01-07-2009 | Article

Risk of type 2 diabetes among individuals with high and low glomerular filtration rates

Authors: C. Lorenzo, S. D. Nath, A. J. G. Hanley, H. E. Abboud, J. A. L. Gelfond, S. M. Haffner

Published in: Diabetologia | Issue 7/2009

Abstract

Aims/hypothesis

Metabolic abnormalities frequently develop prior to the diagnosis of type 2 diabetes and chronic kidney disease. However, it is not known whether GFR predicts the onset of type 2 diabetes.

Methods

Incident diabetes was ascertained in the Insulin Resistance Atherosclerosis Study (IRAS) (n = 864; age 40–69 years; median follow-up 5.2 years [4.5–6.6 years]; 141 incident cases of diabetes). GFR was estimated by the Modification of Diet in Renal Disease equation. We assessed the relationship between GFR and incident diabetes by logistic regression analysis. Results were adjusted for age, sex, ethnicity, clinic location, BMI, systolic blood pressure, antihypertensive treatment, family history of diabetes, insulin sensitivity and secretion, albumin to creatinine ratio, and levels of triacylglycerols, HDL-cholesterol, plasminogen activator inhibitor-1, and fasting and 2 h glucose.

Results

The relationship between GFR and incident diabetes was not linear. This relationship was statistically significant (p = 0.039) using a restricted cubic polynomial spline for GFR as a regression modelling strategy. Participants were stratified by GFR quintiles. Mean values for GFR from the first to the fifth quintile were 60.8, 71.6, 79.8, 88.2 and 109.0 ml min⁻¹ 1.73 m⁻². Relative to the fourth quintile, the odds ratios of incident diabetes for the first, second, third and fifth quintiles were 2.32 (95% CI 1.06–5.05), 1.76 (95% CI 0.80–3.88), 1.26 (95% CI 0.56–2.84) and 2.59 (95% CI 1.18–5.65), respectively.

Conclusions/interpretation

Individuals in the upper and lower ranges of GFR are at increased risk of future diabetes. GFR and type 2 diabetes may share common pathogenic mechanisms.

American Medical Association (2006) Standards of medical care in diabetes—2006. Diabetes Care 29:S4–42

Levey AS, Coresh J, Balk E et al (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139:137–147PubMed

Klausen K, Borch-Johnsen K, Feldt-Rasmussen B et al (2004) Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 110:32–35PubMedCrossRef

Gerstein HC, Mann JF, Yi Q et al (2001) Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286:421–426PubMedCrossRef

Festa A, D'Agostino R, Howard G, Mykkanen L, Tracy RP, Haffner SM (2000) Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kidney Int 58:1703–1710PubMedCrossRef

Mykkanen L, Zaccaro DJ, Wagenknecht LE, Robbins DC, Gabriel M, Haffner SM (1998) Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study. Diabetes 47:793–800PubMedCrossRef

Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D (2004) Predictors of new-onset kidney disease in a community-based population. JAMA 291:844–850PubMedCrossRef

Chen J, Muntner P, Hamm LL et al (2004) The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140:167–174PubMed

Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A (1989) Albuminuria reflects widespread vascular damage: the Steno hypothesis. Diabetologia 32:219–226PubMedCrossRef

10.

Mykkanen L, Zaccaro DJ, O'Leary DH, Howard G, Robbins DC, Haffner SM (1997) Microalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects. The Insulin Resistance Atherosclerosis Study (IRAS). Stroke 28:1710–1716PubMed

11.

Mykkanen L, Haffner SM, Kuusisto J, Pyorala K, Laakso M (1994) Microalbuminuria precedes the development of NIDDM. Diabetes 43:552–557PubMedCrossRef

12.

Wang Z, Hoy WE (2006) Albuminuria as a marker of the risk of developing type 2 diabetes in non-diabetic Aboriginal Australians. Int J Epidemiol 35:1331–1335PubMedCrossRef

13.

Nelson RG, Bennett PH, Beck GJ et al (1996) Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group. N Engl J Med 335:1636–1642PubMedCrossRef

14.

Rudberg S, Persson B, Dahlquist G (1992) Increased glomerular filtration rate as a predictor of diabetic nephropathy—an 8-year prospective study. Kidney Int 41:822–828PubMedCrossRef

15.

Palatini P, Mormino P, Dorigatti F et al (2006) Glomerular hyperfiltration predicts the development of microalbuminuria in stage 1 hypertension: the HARVEST. Kidney Int 70:578–584PubMed

16.

Schmieder RE, Messerli FH, Garavaglia G, Nunez B (1990) Glomerular hyperfiltration indicates early target organ damage in essential hypertension. JAMA 264:2775–2780PubMedCrossRef

17.

Tomaszewski M, Charchar FJ, Maric C et al (2007) Glomerular hyperfiltration: a new marker of metabolic risk. Kidney Int 71:816–821PubMedCrossRef

18.

Wagenknecht LE, Mayer EJ, Rewers M et al (1995) The Insulin Resistance Atherosclerosis Study (IRAS): objectives, design and recruitment results. Ann Epidemiol 5:464–472PubMedCrossRef

19.

Saad MF, Anderson RL, Laws A et al (1994) A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin Resistance Atherosclerosis Study. Diabetes 43:1114–1121PubMedCrossRef

20.

Korytkowski MT, Berga SL, Horwitz MJ (1995) Comparison of the minimal model and the hyperglycemic clamp for measuring insulin sensitivity and acute insulin response to glucose. Metabolism 44:1121–1125PubMedCrossRef

21.

Kroll MH, Chesler R, Hagengruber C, Blank DW, Kestner J, Rawe M (1986) Automated determination of urinary creatinine without sample dilution: theory and practice. Clin Chem 32:446–452PubMed

22.

Herbert V, Lau K, Gottlieb C, Bleicher S (1965) Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25:1375–1384PubMedCrossRef

23.

Declerck P, Collen D (1990) Measurement of plasminogen activator inhibitor 1 (PAI-1) in plasma with various monoclonal antibody-based enzyme-linked immunosorbent assays. Thromb Res 10:S3–S9CrossRef

24.

Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470PubMed

25.

Altman DG (1993) Construction of age-related reference centiles using absolute residuals. Stat Med 12:917–924PubMedCrossRef

26.

Harrell FE (2001) Regression modeling strategies. Springer, New York

27.

Coward RJ, Welsh GI, Yang J et al (2005) The human glomerular podocyte is a novel target for insulin action. Diabetes 54:3095–3102PubMedCrossRef

28.

Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L (1981) Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 30:219–225PubMed

29.

Laakso M, Edelman SV, Brechtel G, Baron AD (1990) Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. J Clin Invest 85:1844–1852PubMedCrossRef

30.

Henegar J, Bigler S, Henegar L, Tuagi S, Hall J (2001) Functional and structural changes in the kidney in the early stages of obesity. Am J Soc Nephrol 12:1211–1217

31.

Lindmark S, Wiklund U, Bjerle P, Eriksson JW (2003) Does the autonomic nervous system play a role in the development of insulin resistance? A study on heart rate variability in first-degree relatives of type 2 diabetes patients and control subjects. Diabet Med 20:399–405PubMedCrossRef

32.

Neumann J, Ligtenberg G, Klein IH et al (2007) Sympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment. Hypertension 49:506–510PubMedCrossRef

33.

Eid A, Bodin S, Ferrier B et al (2006) Intrinsic gluconeogenesis is enhanced in renal proximal tubules of Zucker diabetic fatty rats. J Am Soc Nephrol 17:398–405PubMedCrossRef

34.

Meigs JB, Hu FB, Rifai N, Manson JE (2004) Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 291:1978–1986PubMedCrossRef

35.

Carlsson PO, Berne C, Jansson L (1998) Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats. Diabetologia 41:127–133PubMedCrossRef

36.

Dogra G, Irish A, Chan D, Watts G (2006) Insulin resistance, inflammation, and blood pressure determine vascular dysfunction in CKD. Am J Kidney Dis 48:926–934PubMedCrossRef

37.

Ramos LF, Shintani A, Ikizler TA, Himmelfarb J (2008) Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD. J Am Soc Nephrol 19:593–599PubMedCrossRef

38.

Tikellis C, Wookey PJ, Candido R, Andrikopoulos S, Thomas MC, Cooper ME (2004) Improved islet morphology after blockade of the renin–angiotensin system in the ZDF rat. Diabetes 53:989–997PubMedCrossRef

39.

Jacob S, Henriksen EJ, Fogt DL, Dietze GJ (1996) Effects of trandolapril and verapamil on glucose transport in insulin-resistant rat skeletal muscle. Metabolism 45:535–541PubMedCrossRef

40.

Yamamoto T, Nakagawa T, Suzuki H et al (2007) Urinary angiotensinogen as a marker of intrarenal angiotensin II activity associated with deterioration of renal function in patients with chronic kidney disease. J Am Soc Nephrol 18:1558–1565PubMedCrossRef

41.

Levey AS, Coresh J, Greene T et al (2006) Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145:247–254PubMed

42.

Clase CM, Garg AX, Kiberd BA (2002) Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol 13:1338–1349PubMedCrossRef

43.

Premaratne E, MacIsaac RJ, Finch S, Panagiotopoulos S, Ekinci E, Jerums G (2008) Serial measurements of cystatin C are more accurate than creatinine-based methods in detecting declining renal function in type 1 diabetes. Diabetes Care 31:971–973PubMedCrossRef

Title: Risk of type 2 diabetes among individuals with high and low glomerular filtration rates
Authors: C. Lorenzo
S. D. Nath
A. J. G. Hanley
H. E. Abboud
J. A. L. Gelfond
S. M. Haffner
Publication date: 01-07-2009
Publisher: Springer-Verlag
Published in: Diabetologia / Issue 7/2009
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-009-1361-4

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Risk of type 2 diabetes among individuals with high and low glomerular filtration rates

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Please log in to get access to this content

Other articles of this Issue 7/2009

Relationship between glyco-oxidation, antioxidant status and microalbuminuria in type 2 diabetic patients

Associations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetes

A genome-wide association scan for acute insulin response to glucose in Hispanic-Americans: the Insulin Resistance Atherosclerosis Family Study (IRAS FS)

Prevention of diabetes by a hydrolysed casein-based diet in diabetes-prone BioBreeding rats does not involve restoration of the defective natural regulatory T cell function

Translating TCF7L2: from gene to function

Combined analysis of 19 common validated type 2 diabetes susceptibility gene variants shows moderate discriminative value and no evidence of gene–gene interaction

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page